286 related articles for article (PubMed ID: 32246517)
41. Will Next-Generation Immunotherapy Overcome the Intrinsic Diversity and Low Immunogenicity of Sarcomas to Improve Clinical Benefit?
Chew HY; Chan V; Simpson F; Dolcetti R
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33207697
[TBL] [Abstract][Full Text] [Related]
42. An immunologic approach to the treatment of cancer.
MacEwen EG
Vet Clin North Am; 1977 Feb; 7(1):65-75. PubMed ID: 191975
[No Abstract] [Full Text] [Related]
43. Cancer immunotherapy.
Bergman PJ
Top Companion Anim Med; 2009 Aug; 24(3):130-6. PubMed ID: 19732731
[TBL] [Abstract][Full Text] [Related]
44. Elucidating the transcriptional program of feline injection-site sarcoma using a cross-species mRNA-sequencing approach.
Wei Q; Ramsey SA; Larson MK; Berlow NE; Ochola D; Shiprack C; Kashyap A; Séguin B; Keller C; Löhr CV
BMC Cancer; 2019 Apr; 19(1):311. PubMed ID: 30947707
[TBL] [Abstract][Full Text] [Related]
45. Targeted and immuno-based therapies in sarcoma: mechanisms and advances in clinical trials.
Tang F; Tie Y; Wei YQ; Tu CQ; Wei XW
Biochim Biophys Acta Rev Cancer; 2021 Dec; 1876(2):188606. PubMed ID: 34371128
[TBL] [Abstract][Full Text] [Related]
46. Changes in tumour oxygenation during fractionated hyperthermia and radiation therapy in spontaneous canine sarcomas.
Thrall DE; Larue SM; Pruitt AF; Case B; Dewhirst MW
Int J Hyperthermia; 2006 Aug; 22(5):365-73. PubMed ID: 16891239
[TBL] [Abstract][Full Text] [Related]
47. Stem cells for Snoopy: pet medicines spark a biotech boom.
Ledford H
Nature; 2016 Jun; 534(7607):303-4. PubMed ID: 27306165
[No Abstract] [Full Text] [Related]
48. Immunotherapy and cytokines.
Van Kampen KR
Semin Vet Med Surg Small Anim; 1997 Aug; 12(3):186-92. PubMed ID: 9283244
[TBL] [Abstract][Full Text] [Related]
49. Epidemiological and morphological analysis of feline injection site sarcomas.
Kliczkowska K; Jankowska U; Jagielski D; Czopowicz M; Sapierzyński R
Pol J Vet Sci; 2015; 18(2):313-22. PubMed ID: 26172181
[TBL] [Abstract][Full Text] [Related]
50. The immune landscape of neuroblastoma: Challenges and opportunities for novel therapeutic strategies in pediatric oncology.
Wienke J; Dierselhuis MP; Tytgat GAM; Künkele A; Nierkens S; Molenaar JJ
Eur J Cancer; 2021 Feb; 144():123-150. PubMed ID: 33341446
[TBL] [Abstract][Full Text] [Related]
51. Sarcomas: Immune biomarker expression and checkpoint inhibitor trials.
Zhu MMT; Shenasa E; Nielsen TO
Cancer Treat Rev; 2020 Dec; 91():102115. PubMed ID: 33130422
[TBL] [Abstract][Full Text] [Related]
52. Sarcomas and the immune system: implications for therapeutic strategies.
Francescutti V; Skitzki JJ
Surg Oncol Clin N Am; 2012 Apr; 21(2):341-55. PubMed ID: 22365524
[TBL] [Abstract][Full Text] [Related]
53. Adoptive immunotherapy against sarcomas.
Mesiano G; Leuci V; Giraudo L; Gammaitoni L; Carnevale Schianca F; Cangemi M; Rotolo R; Capellero S; Pignochino Y; Grignani G; Aglietta M; Sangiolo D
Expert Opin Biol Ther; 2015 Apr; 15(4):517-28. PubMed ID: 25516119
[TBL] [Abstract][Full Text] [Related]
54. Current knowledge on feline injection-site sarcoma treatment.
Zabielska-Koczywąs K; Wojtalewicz A; Lechowski R
Acta Vet Scand; 2017 Jul; 59(1):47. PubMed ID: 28716129
[TBL] [Abstract][Full Text] [Related]
55. There and back again: Translating adoptive cell therapy to canine cancer and improving human treatment.
Brill SA; Thamm DH
Vet Comp Oncol; 2021 Sep; 19(3):420-427. PubMed ID: 34169631
[TBL] [Abstract][Full Text] [Related]
56. Novel TCR-based biologics: mobilising T cells to warm 'cold' tumours.
Lowe KL; Cole D; Kenefeck R; OKelly I; Lepore M; Jakobsen BK
Cancer Treat Rev; 2019 Jul; 77():35-43. PubMed ID: 31207478
[TBL] [Abstract][Full Text] [Related]
57. Immunotherapy in soft-tissue sarcoma.
Ayodele O; Razak ARA
Curr Oncol; 2020 Feb; 27(Suppl 1):17-23. PubMed ID: 32174754
[TBL] [Abstract][Full Text] [Related]
58. Immunological aspects of mammary tumors in dogs and cats: a survey including own studies and pertinent literature.
Rutten VP; Misdorp W; Gauthier A; Estrada M; Mialot JP; Parodi AL; Rutteman GR; Weyer K
Vet Immunol Immunopathol; 1990 Nov; 26(3):211-25. PubMed ID: 2264285
[TBL] [Abstract][Full Text] [Related]
59. Response of canine soft tissue sarcomas to radiation or radiation plus hyperthermia: a randomized phase II study.
Gillette SM; Dewhirst MW; Gillette EL; Thrall DE; Page RL; Powers BE; Withrow SJ; Rosner G; Wong C; Sim DA
Int J Hyperthermia; 1992; 8(3):309-20. PubMed ID: 1607736
[TBL] [Abstract][Full Text] [Related]
60. Immunotherapy for Bone and Soft Tissue Sarcomas.
Uehara T; Fujiwara T; Takeda K; Kunisada T; Ozaki T; Udono H
Biomed Res Int; 2015; 2015():820813. PubMed ID: 26167500
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
